Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Dividends By The Numbers In July 2020

12:24pm, Wednesday, 05'th Aug 2020
July 2020 saw significant improvements for dividend-paying firms in the U.S. stock market.
Merck & Co is to pay $10 million to Hanmi to repurpose a drug discarded by Johnson & Johnson in obesity into a therapy for the fatty liver disease also known as NASH.

Merck, Hanmi sign $870M deal for NASH drug

05:43pm, Tuesday, 04'th Aug 2020
Hanmi will retain options for the drug, efinopegdutide, in Korea under the deal, in which Merck is paying the Seoul-based company $10 million upfront and up to $860 for development, regulatory and com
Merck and Hanmi Pharmaceutical Enter into Licensing Agreement to Develop Efinopegdutide, an Investigational Once-Weekly Therapy for NASH
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Hanmi...
The following slide deck was published by Hanmi Financial Corporation in conjunction with this event.
LOS ANGELES, July 29, 2020 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC) (“Hanmi”), the holding company for Hanmi Bank, today announced that in response to the continued uncertain
With me to discuss Hanmi Financial's second quarter 2020 earnings are Bonnie Lee, President and CEO; Anthony Kim, Chief Banking Officer; and Ron Santarosa, Chief Financial Officer. Ms. Lee will begin
Hanmi Financial (HAFC) delivered earnings and revenue surprises of 114.29% and 31.01%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Hanmi Financial Corp (NASDAQ:HAFC) Q2 2020 Earnings Conference Call July 28, 2020, 17:00 ET Company Participants Lasse Glassen - ADDO Investor Relations Bonita Lee - President, CEO & Director Anth

Hanmi Reports Second Quarter 2020 Results

08:15pm, Tuesday, 28'th Jul 2020
2020 Second Quarter Highlights:     * Net income of $9.2 million, or $0.30 per diluted share, up from net income of $2.4 million, or $0.08 per diluted share, for the prior quarter and up from ne
Spectrum Pharmaceuticals Announces Positive Topline Results in HER2 Exon20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Trial
Hanmi Financial (HAFC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LOS ANGELES, July 10, 2020 -- Hanmi Financial Corporation (Nasdaq: HAFC) (“Hanmi”), the holding company for Hanmi Bank, today announced that it will report second quarter 2020.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE